Opeyemi Deji-Oloruntoba

Dr. Opeyemi Deji-Oloruntoba

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2025 in Applied Biosciences
Verified
Journal Article
Open access
PDF file
Opeyemi Deji-OloruntobaOpeyemi Deji-Oloruntoba
Opeyemi Deji-Oloruntoba
TETaiwo Olayemi Elufioye
Taiwo Olayemi Elufioye
SAStephen Adefegha
Stephen Adefegha
MJMiran Jang
Miran Jang
Experimental research demands the selection of appropriate models to align with study objectives and conditions. Traditional experimental models, such as in vivo animal studies and in vitro systems like organoids, present nutraceutical and pharmaceutical research limitations such as high cost, ethical concerns, long lifespan, and difficult genetic manipulation. Caenorhabditis elegans has proved to be a valuable model as a result of its genetic and physiological similarities to higher organisms, fully sequenced genome, short life cycle, and transparency. These features enable high-throughput screening, molecular pathway analysis, and lifespan and healthspan assays. C. elegans has significantly advanced the discovery of bioactive molecules with therapeutic potential, shedding light on aging, neurodegeneration, metabolic disorders, and immune responses. Its utility in pharmacokinetics and validation of nutraceuticals underscores its role in longevity and metabolic health research. Additionally, its conserved stress response, apoptosis, and pathogen recognition pathways facilitate the study of pharmacological interventions for inflammation, oxidative stress, and infections. This study evaluates the applicability of C. elegans as a model for in vivo screening, analyses its role in drug efficacy testing, and discusses relevant advancements, associated difficulties, and what to expect of C. elegans in research.

Verified
Journal Article
Open access
PDF file
Opeyemi Deji-OloruntobaOpeyemi Deji-Oloruntoba
Opeyemi Deji-Oloruntoba
JBJames Onoruoiza Balogun
James Onoruoiza Balogun
TETaiwo Olayemi Elufioye
Taiwo Olayemi Elufioye
Simeon Okechukwu AjakweSimeon Okechukwu Ajakwe
Simeon Okechukwu Ajakwe
Hyperuricemia, defined as elevated serum uric acid (SUA) levels (>6.8 mg/dL), is traditionally linked to gout and nephrolithiasis but is increasingly implicated in insulin resistance (IR) and type 2 diabetes mellitus (T2DM). Epidemiological studies, such as NHANES, suggest hyperuricemia increases the risk of T2DM by 1.6 to 2.5 times. Mechanistically, uric acid promotes IR via oxidative stress, chronic inflammation, endothelial dysfunction, and adipocyte dysregulation. Despite growing evidence, significant gaps remain in understanding these pathways, with existing studies often limited by observational designs and short intervention durations. A bibliographic analysis of studies from 2004–2024 using Web of Science and VOSviewer highlights a growing focus on hyperuricemia’s interplay with inflammation, oxidative stress, and metabolic disorders. However, inconsistencies in therapeutic outcomes and limited exploration of causality underscore the need for further research. We also explored the importance of gender stratification and the limitations of the binary model for the relationship between hyperuricemia and insulin resistance. This review emphasizes the importance of addressing these gaps to optimize hyperuricemia management as a potential strategy for diabetes prevention and metabolic health improvement.

1 August 2024 in BioMedInformatics
Verified
Journal Article
Open access
PDF file
TATagne Poupi Theodore Armand
Tagne Poupi Theodore Armand
MD ARIFUL ISLAM MOZUMERMD ARIFUL ISLAM MOZUMER
MD ARIFUL ISLAM MOZUMER
KCkouayep sonia carole
kouayep sonia carole
Opeyemi Deji-OloruntobaOpeyemi Deji-Oloruntoba
Opeyemi Deji-Oloruntoba
Hee-Cheol KimHee-Cheol Kim
Hee-Cheol Kim
Simeon Okechukwu AjakweSimeon Okechukwu Ajakwe
Simeon Okechukwu Ajakwe
(1) Background: Among lung diseases, idiopathic pulmonary fibrosis (IPF) appears to be the most common type and causes scarring (fibrosis) of the lungs. IPF disease patients are recommended to undergo lung transplants, or they may witness progressive and irreversible lung damage that will subsequently lead to death. In cases of irreversible damage, it becomes important to predict the patient’s mortality status. Traditional healthcare does not provide sophisticated tools for such predictions. Still, because artificial intelligence has effectively shown its capability to manage crucial healthcare situations, it is possible to predict patients’ mortality using machine learning techniques. (2) Methods: This research proposed a soft voting ensemble model applied to the top 30 best-fit clinical features to predict mortality risk for patients with idiopathic pulmonary fibrosis. Five machine learning algorithms were used for it, namely random forest (RF), support vector machine (SVM), gradient boosting machine (GBM), XGboost (XGB), and multi-layer perceptron (MLP). (3) Results: A soft voting ensemble method applied with the combined results of the classifiers showed an accuracy of 79.58%, sensitivity of 86%, F1-score of 84%, prediction error of 0.19, and responsiveness of 0.47. (4) Conclusions: Our proposed model will be helpful for physicians to make the right decision and keep track of the disease, thus reducing the mortality risk, improving the overall health condition of patients, and managing patient stratification.

17 January 2024
Verified
Book Chapter
Closed access
Simeon Okechukwu AjakweSimeon Okechukwu Ajakwe
Simeon Okechukwu Ajakwe
NENkechi Faustina Esomonu
Nkechi Faustina Esomonu
Opeyemi Deji-OloruntobaOpeyemi Deji-Oloruntoba
Opeyemi Deji-Oloruntoba
IAIhunanya Udodiri Ajakwe
Ihunanya Udodiri Ajakwe
JLJae-Min Lee
Jae-Min Lee
DKDong Seong Kim
Dong Seong Kim
Over the years, economic loss in the agricultural sector has been attributed to the late detection of varying plant diseases due to incongruent detection technologies. With the advent of disruptive technologies and their deployment, such as incorporating artificial intelligence (AI) models into unmanned autonomous vehicles for real-time monitoring, the curtailment of losses and inadvertent waste of agricultural produce can be significantly addressed. This study examines the role of deploying AI models in improving the early and accurate detection of crop lesions for prompt, intuitive, and decisive action to forestall recurrence and guarantee a return on investment to farmers. Furthermore, the chapter established scientific basis for the acceleration of crop yields through allied mechano-biosynthesis in a quest to cushion the effect of the contemporary global food crisis. Connected intelligence in smart farming can be achieved through convergence technology for cost effective agro-allied production by improving the limitations of UAVs and AI-models.

1 May 2026 in Sustainability
Verified
Journal Article
Open access
PDF file
Opeyemi Deji-OloruntobaOpeyemi Deji-Oloruntoba
Opeyemi Deji-Oloruntoba
AOAdefarati Oloruntoba
Adefarati Oloruntoba
HBHelen Binang
Helen Binang
OOOlusanya Olasehinde
Olusanya Olasehinde
Climate change is increasingly recognized as a source of psychological distress, yet the prevalence, predictors, and behavioral implications of climate anxiety remain unevenly understood. This study examines climate anxiety, its key drivers, and associated behavioral responses in a multi-country sample of adults. A cross-sectional online survey was conducted across 21 countries using the Climate Change Anxiety Scale (CCAS), alongside measures of awareness, coping strategies, social support, and food-related behaviors, including food waste reduction, increased plant-based food consumption, and home or community gardening. Analyses included descriptive statistics, exploratory factor analysis (EFA), and multivariable regression. Given the uneven country-level representation, results are reported as pooled patterns with a few exploratory cross-country comparisons. Climate anxiety was widely reported, with over 60% of participants indicating that climate challenges were emotionally overwhelming. Regression analyses showed that climate awareness and frequency of climate-related thinking were positively associated with higher anxiety, although the effect sizes were small and explanatory power was limited (R2 = 0.055). EFA identified two related dimensions: cognitive concern about future impacts and affective distress. Climate anxiety across countries showed modest variation (2.44–3.23) and no statistically significant differences, despite variation in awareness. A gap between concern and climate action was evident: only 39.1% reported environmentally motivated dietary changes. Cost, limited availability, and lack of information were the main barriers to climate action, and only 24.4% reported frequent social support. These findings indicate that climate anxiety is shaped by both psychological and structural factors, and that reducing it requires not only increasing awareness but also enabling conditions that support meaningful climate action.

5 June 2025 in Foods
Verified
Journal Article
Open access
PDF file
예빈 김예빈 김
예빈 김
Opeyemi Deji-OloruntobaOpeyemi Deji-Oloruntoba
Opeyemi Deji-Oloruntoba
YCYunji Choe
Yunji Choe
JLJi Yeon Lee
Ji Yeon Lee
JPJeong-Yong Park
Jeong-Yong Park
MJMiran Jang
Miran Jang
In this study, we investigated the effects of MG4244 on intestinal permeability, oxidative stress, and lipid accumulation in Caenorhabditis elegans with metabolic inflammation induced by Pseudomonas aeruginosa (PA) and a high-glucose diet (HGD). The worms infected with PA exhibited increased intestinal permeability and reactive oxygen species (ROS) production, which were improved upon MG4244 treatment. Also, MG4244 inhibited lipid and ROS accumulation induced by an HGD. In addition, MG4244-treated worms showed extended lifespans under various conditions. To elucidate the mechanism of the MG4244 effects, we conducted further investigation using mutant strains with knockdown of genes associated with the AMP-activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPK) pathways. The results demonstrated that the MG4244 effect on lipid metabolism was primarily mediated through the AMPK signaling pathway. Furthermore, MG4244 enhanced pathogen resistance by MAPK signaling pathways, mitigating stress responses, and maintaining intestinal integrity. In further studies, combined treatment with PA and an HGD significantly increased intestinal permeability, lipid, and ROS levels, confirming their negative synergistic effects. However, MG4244 under PA and HGD co-treatment conditions effectively mitigated these health disruptions, suggesting a protective role of MG4244. This study provides an in vivo platform using C. elegans to evaluate probiotic efficacy related to the intestinal environment. Also, our results highlight the therapeutic potential of MG4244 in improving resilience to metabolic inflammation through gut-targeted mechanisms.